BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 26944678)

  • 1. UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia.
    Benyoucef A; Palii CG; Wang C; Porter CJ; Chu A; Dai F; Tremblay V; Rakopoulos P; Singh K; Huang S; Pflumio F; Hébert J; Couture JF; Perkins TJ; Ge K; Dilworth FJ; Brand M
    Genes Dev; 2016 Mar; 30(5):508-21. PubMed ID: 26944678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia.
    Correia NC; Melão A; Póvoa V; Sarmento L; Gómez de Cedrón M; Malumbres M; Enguita FJ; Barata JT
    Oncotarget; 2016 Feb; 7(7):8268-81. PubMed ID: 26882564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia.
    Van der Meulen J; Sanghvi V; Mavrakis K; Durinck K; Fang F; Matthijssens F; Rondou P; Rosen M; Pieters T; Vandenberghe P; Delabesse E; Lammens T; De Moerloose B; Menten B; Van Roy N; Verhasselt B; Poppe B; Benoit Y; Taghon T; Melnick AM; Speleman F; Wendel HG; Van Vlierberghe P
    Blood; 2015 Jan; 125(1):13-21. PubMed ID: 25320243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells.
    Cardoso BA; de Almeida SF; Laranjeira AB; Carmo-Fonseca M; Yunes JA; Coffer PJ; Barata JT
    Leukemia; 2011 Oct; 25(10):1578-86. PubMed ID: 21647153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.
    Li Y; Deng C; Hu X; Patel B; Fu X; Qiu Y; Brand M; Zhao K; Huang S
    Oncogene; 2012 Nov; 31(48):5007-18. PubMed ID: 22310283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.
    Patel B; Kang Y; Cui K; Litt M; Riberio MS; Deng C; Salz T; Casada S; Fu X; Qiu Y; Zhao K; Huang S
    Leukemia; 2014 Feb; 28(2):349-61. PubMed ID: 23698277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site- and allele-specific polycomb dysregulation in T-cell leukaemia.
    Navarro JM; Touzart A; Pradel LC; Loosveld M; Koubi M; Fenouil R; Le Noir S; Maqbool MA; Morgado E; Gregoire C; Jaeger S; Mamessier E; Pignon C; Hacein-Bey-Abina S; Malissen B; Gut M; Gut IG; Dombret H; Macintyre EA; Howe SJ; Gaspar HB; Thrasher AJ; Ifrah N; Payet-Bornet D; Duprez E; Andrau JC; Asnafi V; Nadel B
    Nat Commun; 2015 Jan; 6():6094. PubMed ID: 25615415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel TAL1 targets beyond protein-coding genes: identification of TAL1-regulated microRNAs in T-cell acute lymphoblastic leukemia.
    Correia NC; Durinck K; Leite AP; Ongenaert M; Rondou P; Speleman F; Enguita FJ; Barata JT
    Leukemia; 2013 Jul; 27(7):1603-6. PubMed ID: 23448994
    [No Abstract]   [Full Text] [Related]  

  • 9. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
    Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
    J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.
    Kusy S; Gerby B; Goardon N; Gault N; Ferri F; Gérard D; Armstrong F; Ballerini P; Cayuela JM; Baruchel A; Pflumio F; Roméo PH
    J Exp Med; 2010 Sep; 207(10):2141-56. PubMed ID: 20855495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia.
    Astolfi A; Vendemini F; Urbini M; Melchionda F; Masetti R; Franzoni M; Libri V; Serravalle S; Togni M; Paone G; Montemurro L; Bressanin D; Chiarini F; Martelli AM; Tonelli R; Pession A
    Oncotarget; 2014 Jan; 5(1):120-30. PubMed ID: 24334727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone demethylase LSD1-mediated repression of GATA-2 is critical for erythroid differentiation.
    Guo Y; Fu X; Jin Y; Sun J; Liu Y; Huo B; Li X; Hu X
    Drug Des Devel Ther; 2015; 9():3153-62. PubMed ID: 26124638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.
    Sanda T; Lawton LN; Barrasa MI; Fan ZP; Kohlhammer H; Gutierrez A; Ma W; Tatarek J; Ahn Y; Kelliher MA; Jamieson CH; Staudt LM; Young RA; Look AT
    Cancer Cell; 2012 Aug; 22(2):209-21. PubMed ID: 22897851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIB2 reinforces the oncogenic transcriptional program controlled by the TAL1 complex in T-cell acute lymphoblastic leukemia.
    Tan SH; Yam AW; Lawton LN; Wong RW; Young RA; Look AT; Sanda T
    Leukemia; 2016 Apr; 30(4):959-62. PubMed ID: 26202930
    [No Abstract]   [Full Text] [Related]  

  • 15. Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma.
    Yi J; Shi X; Xuan Z; Wu J
    Cancer Lett; 2021 Feb; 499():188-200. PubMed ID: 33253789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming.
    Mansour AA; Gafni O; Weinberger L; Zviran A; Ayyash M; Rais Y; Krupalnik V; Zerbib M; Amann-Zalcenstein D; Maza I; Geula S; Viukov S; Holtzman L; Pribluda A; Canaani E; Horn-Saban S; Amit I; Novershtern N; Hanna JH
    Nature; 2012 Aug; 488(7411):409-13. PubMed ID: 22801502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of E-cadherin expression by the histone demethylase UTX in colon cancer cells.
    Zha L; Cao Q; Cui X; Li F; Liang H; Xue B; Shi H
    Med Oncol; 2016 Mar; 33(3):21. PubMed ID: 26819089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NFKB1 is a direct target of the TAL1 oncoprotein in human T leukemia cells.
    Chang PY; Draheim K; Kelliher MA; Miyamoto S
    Cancer Res; 2006 Jun; 66(12):6008-13. PubMed ID: 16778171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel translocation t(1;5)(p32;q31) that was not associated with the TAL1 rearrangement in a case of T lymphoblastic leukemia/lymphoma.
    Cho HS; Kim MK; Bae YK
    Korean J Lab Med; 2009 Jun; 29(3):199-203. PubMed ID: 19571616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.
    Palomero T; Odom DT; O'Neil J; Ferrando AA; Margolin A; Neuberg DS; Winter SS; Larson RS; Li W; Liu XS; Young RA; Look AT
    Blood; 2006 Aug; 108(3):986-92. PubMed ID: 16621969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.